Characterization of an anaphylactoid reaction to omalizumab
- 1 April 2006
- journal article
- case report
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 96 (4) , 624-627
- https://doi.org/10.1016/s1081-1206(10)63560-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Intravenous immunoglobulins in neurological disorders: safety issuesNeurological Sciences, 2003
- Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthmaAnnals of Allergy, Asthma & Immunology, 2003
- Omalizumab is effective in the long-term control of severe allergic asthmaAnnals of Allergy, Asthma & Immunology, 2003
- Monoclonal anti-IgE antibody: a novel therapy for allergic airways diseaseAnnals of Allergy, Asthma & Immunology, 2002
- Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune DiseasesPharmacology, 2001
- Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four casesAnnals of the Rheumatic Diseases, 2000
- Autoimmune Skin Rashes Associated with Etanercept for Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- Complications of intravenous immune globulin treatment in neurologic diseaseNeurology, 1996